v3.23.3

Earnings (Loss) Per Common Share (Tables)

12 Months Ended

Jun. 30, 2023

Earnings (Loss) Per Common Share [Abstract]

Schedule of Earnings (loss) Per Share, Basic and Diluted

The following table summarizes the components of the earnings (loss) per common share calculation (in thousands, except per share amounts):

​

​	​	​	​	​	​	​	​
​	​	Year Ended					​
​	​	June 30,					​
​	​	2023			2022		​
Basic and diluted numerator:	​	​	​	​	​	​	​
​	​	​	​	​	​	​	​
Net loss attributable to iBio, Inc. from continuing operations	​	$	(29,311)		$	(29,512)	​
Preferred stock dividends – iBio CMO Preferred Tracking Stock	​		—	​		(88)	​
Net loss available to iBio, Inc. stockholders from continuing operations	​	$	(29,311)	​	$	(29,600)	​
​	​	​	​	​	​	​	​
Net loss available to iBio, Inc. stockholders from discontinued operations	​	$	(35,699)	​	$	(20,791)	​
​	​	​	​	​	​	​	​
Net loss available to iBio, Inc. stockholders - total	​	$	(65,010)	​	$	(50,391)	​
​	​	​	​	​	​	​	​
Basic and diluted denominator:	​	​	​	​	​	​	​
​	​	​	​	​	​	​	​
Weighted-average common shares outstanding	​		12,245	​		8,721	​
​	​		​	​		​	​
Per share amount - continuing operations	​	$	(2.39)	​	$	(3.39)	​
Per share amount - discontinued operations	​	$	(2.92)	​	$	(2.39)	​
Per share amount - total	​	$	(5.31)	​	$	(5.78)	​

Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share

In Fiscal Years 2023 and 2022, the Company incurred net losses which cannot be diluted; therefore, basic and diluted loss per common share is the same. As of June 30, 2023 and 2022, shares issuable which could potentially dilute future earnings included were as follows:

​	​	​	​	​
​	​	June 30,
​		2023		2022
​	​	(in thousands)
Stock options		292		622
Restricted stock units		248		51
Warrants		5,871		21
Series 2022 Preferred	​	—	​	*
Shares excluded from the calculation of diluted loss per share		6,411		694
​	​	​	​	​
* Less than 1,000	​	​	​	​

X

- References

No definition available.

+ Details

Name:	us-gaap_EarningsPerShareAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482662/260-10-50-1

+ Details

Name:	us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482662/260-10-50-1

+ Details

Name:	us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration